LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 658 | 469 | 3933 | 0.1194 | -0.1232 |
Hs 578T | WZ3105 | 10 | uM | LJP5 | 72 | hr | 658 | 454 | 3933 | 0.1154 | -0.1342 |
Hs 578T | XMD11-50 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3410 | 3761 | 0.9068 | 0.9237 |
Hs 578T | XMD11-50 | 0.12 | uM | LJP6 | 72 | hr | 658 | 3109 | 3761 | 0.8267 | 0.8543 |
Hs 578T | XMD11-50 | 0.37 | uM | LJP6 | 72 | hr | 658 | 2800 | 3761 | 0.7447 | 0.7787 |
Hs 578T | XMD11-50 | 1.11 | uM | LJP6 | 72 | hr | 658 | 2353 | 3761 | 0.6257 | 0.6595 |
Hs 578T | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 658 | 1683 | 3761 | 0.4476 | 0.4522 |
Hs 578T | XMD11-50 | 10 | uM | LJP6 | 72 | hr | 658 | 616 | 3761 | 0.1639 | -0.0259 |
Hs 578T | XMD11-85h | 0.04 | uM | LJP6 | 72 | hr | 658 | 3506 | 3761 | 0.9321 | 0.9448 |
Hs 578T | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 658 | 3392 | 3761 | 0.9020 | 0.9196 |
Hs 578T | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 658 | 3316 | 3761 | 0.8819 | 0.9024 |
Hs 578T | XMD11-85h | 1.11 | uM | LJP6 | 72 | hr | 658 | 3405 | 3761 | 0.9053 | 0.9224 |
Hs 578T | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 658 | 3049 | 3761 | 0.8107 | 0.8399 |
Hs 578T | XMD11-85h | 10 | uM | LJP6 | 72 | hr | 658 | 1044 | 3761 | 0.2775 | 0.2005 |
Hs 578T | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 658 | 797 | 3933 | 0.2028 | 0.0772 |
Hs 578T | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 658 | 770 | 3933 | 0.1959 | 0.0627 |
Hs 578T | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 658 | 778 | 3933 | 0.1978 | 0.0670 |
Hs 578T | XMD16-144 | 1.11 | uM | LJP5 | 72 | hr | 658 | 705 | 3933 | 0.1793 | 0.0271 |
Hs 578T | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 658 | 605 | 3933 | 0.1539 | -0.0323 |
Hs 578T | XMD16-144 | 10 | uM | LJP5 | 72 | hr | 658 | 484 | 3933 | 0.1231 | -0.1125 |
Hs 578T | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3741 | 3933 | 0.9511 | 0.9613 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 658 | 3750 | 3933 | 0.9536 | 0.9634 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3756 | 3933 | 0.9548 | 0.9643 |
Hs 578T | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 658 | 3767 | 3933 | 0.9577 | 0.9668 |
Hs 578T | Erlotinib | 3.33 | uM | LJP5 | 72 | hr | 658 | 3616 | 3933 | 0.9192 | 0.9357 |